Cargando…

BRCA1 founder mutations compared to ovarian cancer in Belarus

In Belarus and other Slavic countries, founder mutations in the BRCA1 gene are responsible for a significant proportion of breast cancer cases, but the data on contribution of these mutations to ovarian cancers are limited. To estimate the proportion of ovarian cancers in Belarus, which are dependen...

Descripción completa

Detalles Bibliográficos
Autores principales: Savanevich, Alena, Oszurek, Oleg, Lubiński, Jan, Cybulski, Cezary, Dębniak, Tadeusz, Narod, Steven A., Gronwald, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164833/
https://www.ncbi.nlm.nih.gov/pubmed/24770866
http://dx.doi.org/10.1007/s10689-014-9721-8
_version_ 1782335016333737984
author Savanevich, Alena
Oszurek, Oleg
Lubiński, Jan
Cybulski, Cezary
Dębniak, Tadeusz
Narod, Steven A.
Gronwald, Jacek
author_facet Savanevich, Alena
Oszurek, Oleg
Lubiński, Jan
Cybulski, Cezary
Dębniak, Tadeusz
Narod, Steven A.
Gronwald, Jacek
author_sort Savanevich, Alena
collection PubMed
description In Belarus and other Slavic countries, founder mutations in the BRCA1 gene are responsible for a significant proportion of breast cancer cases, but the data on contribution of these mutations to ovarian cancers are limited. To estimate the proportion of ovarian cancers in Belarus, which are dependent on BRCA1 Slavic founder mutations, we sought the presence of three most frequent mutations (BRCA1: 5382insC, C61G and, 4153delA) in 158 consecutive unselected cases of ovarian cancer. One of the three founder mutations was present in 25 of 158 unselected cases of ovarian cancer (15.8 %). We recommend that all cases of ovarian cancer in Belarus be offered genetic testing for these founder mutations. Furthermore, genetic testing of the Belarusian population will provide the opportunity to prevent a significant proportion of ovarian cancer.
format Online
Article
Text
id pubmed-4164833
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-41648332014-09-18 BRCA1 founder mutations compared to ovarian cancer in Belarus Savanevich, Alena Oszurek, Oleg Lubiński, Jan Cybulski, Cezary Dębniak, Tadeusz Narod, Steven A. Gronwald, Jacek Fam Cancer Short Communication In Belarus and other Slavic countries, founder mutations in the BRCA1 gene are responsible for a significant proportion of breast cancer cases, but the data on contribution of these mutations to ovarian cancers are limited. To estimate the proportion of ovarian cancers in Belarus, which are dependent on BRCA1 Slavic founder mutations, we sought the presence of three most frequent mutations (BRCA1: 5382insC, C61G and, 4153delA) in 158 consecutive unselected cases of ovarian cancer. One of the three founder mutations was present in 25 of 158 unselected cases of ovarian cancer (15.8 %). We recommend that all cases of ovarian cancer in Belarus be offered genetic testing for these founder mutations. Furthermore, genetic testing of the Belarusian population will provide the opportunity to prevent a significant proportion of ovarian cancer. Springer Netherlands 2014-04-27 2014 /pmc/articles/PMC4164833/ /pubmed/24770866 http://dx.doi.org/10.1007/s10689-014-9721-8 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Short Communication
Savanevich, Alena
Oszurek, Oleg
Lubiński, Jan
Cybulski, Cezary
Dębniak, Tadeusz
Narod, Steven A.
Gronwald, Jacek
BRCA1 founder mutations compared to ovarian cancer in Belarus
title BRCA1 founder mutations compared to ovarian cancer in Belarus
title_full BRCA1 founder mutations compared to ovarian cancer in Belarus
title_fullStr BRCA1 founder mutations compared to ovarian cancer in Belarus
title_full_unstemmed BRCA1 founder mutations compared to ovarian cancer in Belarus
title_short BRCA1 founder mutations compared to ovarian cancer in Belarus
title_sort brca1 founder mutations compared to ovarian cancer in belarus
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164833/
https://www.ncbi.nlm.nih.gov/pubmed/24770866
http://dx.doi.org/10.1007/s10689-014-9721-8
work_keys_str_mv AT savanevichalena brca1foundermutationscomparedtoovariancancerinbelarus
AT oszurekoleg brca1foundermutationscomparedtoovariancancerinbelarus
AT lubinskijan brca1foundermutationscomparedtoovariancancerinbelarus
AT cybulskicezary brca1foundermutationscomparedtoovariancancerinbelarus
AT debniaktadeusz brca1foundermutationscomparedtoovariancancerinbelarus
AT narodstevena brca1foundermutationscomparedtoovariancancerinbelarus
AT gronwaldjacek brca1foundermutationscomparedtoovariancancerinbelarus